Canada markets closed

Euro Manganese Inc. (EMN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0750-0.0050 (-6.25%)
At close: 03:19PM EDT
Full screen
Previous Close0.0800
Open0.0750
Bid0.0700 x 0
Ask0.0750 x 0
Day's Range0.0750 - 0.0750
52 Week Range0.0650 - 0.2700
Volume120,587
Avg. Volume84,273
Market Cap30.2M
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • GlobeNewswire

    Euro Manganese Receives Approval of Environmental and Social Impact Assessment for Chvaletice Manganese Project and Appoints Project Director

    VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company" or "EMN") is pleased to announce it has received approval of the Environmental and Social Impact Assessment ("ESIA") for the Chvaletice Manganese Project ("Chvaletice Project" or the "Project") from the Czech Ministry of Environment. In addition, the Company is pleased to appoint Mr. Tim Kindred, an experienced, large-scale project delivery profess

  • GlobeNewswire

    Euro Manganese Welcomes the European Union’s Final Approval of the Critical Raw Materials Act

    VANCOUVER, British Columbia, March 24, 2024 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company" or "EMN") today provided follow up comments to the Company’s announcement dated March 20, 2023 regarding the European Commission’s proposed Critical Raw Materials Act (“CRMA” or the “Act”), which outlines how the European Union (the "EU") intends to ensure a secure and sustainable supply of critical raw materials that are essential in supporting th

  • GlobeNewswire

    Investor Webinar

    VANCOUVER, British Columbia, March 24, 2024 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company" or "EMN") is pleased to invite shareholders and investors to a webinar on Wednesday, 27 March 2024 in Australia at 7:15 am AWST / 10:15 am AEDT (Tuesday, 26 March 2024 at 4:15 pm PDT / 7:15 pm EDT in North America) where President and CEO, Dr. Matthew James, will provide a Company update and engage in a Q&A session. Details of the event are as foll